Duke University: Alzheimer Disease trials
The registry lists 15 Alzheimer Disease studies with Duke University as lead sponsor. 4 are open to participants now and 3 have results posted.
Phase 1 1Phase 2 1Phase 4 2No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)Enrolling by invitationNCT07425106Not applicable
- Olfactory BiopsiesRecruitingNCT07021040Not applicable
- ADRC Clinical Cohort (Alzheimer's Disease)RecruitingNCT06703541
- Retinal Imaging in Neurodegenerative DiseaseRecruitingNCT03233646
- Effect of Blueberry Supplementation on Alzheimer's BiomarkersCompletedNCT05172128Not applicableResults posted
- Trial of Rifaximin in Probable Alzheimer's DiseaseCompletedNCT03856359Phase 2Results posted
- Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative CareCompletedNCT01993836Phase 4Results posted
- Risk Prediction for Alzheimer Dementia With Brain Imaging and GeneticsWithdrawnNCT03641768Not applicable
- Blood Biomarker of Alzheimer's Disease (AD)CompletedNCT03340571
- Bilateral Brain Dynamics in Cognition and AgingCompletedNCT03224988
- The Cognitive Resilience StudyCompletedNCT03016702Not applicable
- Novel Retinal Imaging Biomarkers in Early Alzheimer's DiseaseCompletedNCT01937221
- Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD DementiasCompletedNCT01730430
- Markers of Alzheimers Disease After Propofol or Isoflurane AnesthesiaCompletedNCT01640275Phase 1
- Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease PatientsTerminatedNCT00369603Phase 4